1-1 of 1
Jonas Schmidt, MD
Close
Sort by
Journal Articles

Belimumab, a Neutralizing BAFF (B Cell Activating Factor) Antibody, Enhances the Susceptibility of Chronic Lymphoid Leukemia (CLL) Cells to Abt-199 Treatment

Jonas Schmidt, MD, Julia Wild, MSc, Benedikt Strunz, MD, Lothar Kanz, MD, Helmut R Salih, MD
Journal: Blood
Blood (2015) 126 (23): 2947.
https://doi.org/10.1182/blood.V126.23.2947.2947
Published: 2015